Health Care Systems - OHE

Office of Health Economics

Leading intellectual authority on global health economics

Search publications, topics, authors and more

Newsletter SignupSubscribe

News & Insights

News
Events
Insights
Bulletin

News
Events
Insights
Bulletin

News & Insights

News
Events
Insights
Bulletin

Newsletter SignupSubscribe

News
Events
Insights
Bulletin

Search publications, topics, authors and more

Research & Publications
News & Insights
Education
Innovation Policy Prize

Events
About Us
OHE Experts
Join OHE
Contact Us

Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:

Antimicrobial Resistance (AMR)
Biosimilars
Cell and Gene Therapies
Chronic Diseases
Combination Therapies
COVID-19 Research
Digital Health
Drug Development/R&D
Emerging Markets
EQ-5D and PROMs
Indication-Based Pricing
Health Care Systems
Health Data and Statistics
Health Technology Assessment
Precision Medicine
Prevention
Real-World Evidence
Sustainability
Use of Medicines
Value-Based Pricing
Vaccine Research

Economics of Innovation
Measuring and Valuing Outcomes
Policy, Organisation and Incentives in Health Systems
Value, Affordability and Decision Making

News & Insights

News
Events
Insights
Bulletin

Education

Education Hub
OHE Graduate School
EVIA Programme

Innovation Policy Prize

The Prize Fund
2024 Prize Fund
2022 Prize Fund

Search publications, topics, authors and more

Latest Research & Publications

Health Technology Assessment…
Economics of Innovation
Health Policy and Regulation

Routine Funding in the NHS in the UK of Medicines Authorised Between 2011 and 2016 via the European Centralised Procedure

Antimicrobial Resistance (AMR)
Measuring and Valuing Outcomes
Generics

Antimicrobials Resistance: A Call for Multi-disciplinary Action. How Can HTA Help?

Health Data and Statistics
Economics of Innovation

Data Governance Arrangements for Real-World Evidence: South Korea

Measuring and Valuing Outcomes
Clinical Outcomes

A New Valuation Method: Directly Eliciting Personal Utility Functions

Health Care Systems
Policy, Organisation and…
Quality of Care

Interventions that Encourage High-value Nursing Home Care: Lessons for the UK

Measuring and Valuing Outcomes
Clinical Outcomes

Why Do Immigrants Report Lower Life Satisfaction?

Health Technology Assessment…
Determining Value

Ten Years of the NIHR: Achievements and Challenges for the Next Decade

Antimicrobial Resistance (AMR)
Measuring and Valuing Outcomes
Generics

Additional Elements of Value for Health Technology Assessment Decisions

All Publications

Filter by:

Antimicrobial Resistance (AMR)

Biosimilars

Cell and Gene Therapies

Chronic Diseases

Combination Therapies

COVID-19 Research

Digital Health

Drug Development/R&D

Emerging Markets

EQ-5D and PROMs

Indication-Based Pricing

Health Care Systems

Health Data and Statistics

Health Technology Assessment

Precision Medicine

Prevention

Real-World Evidence

Sustainability

Use of Medicines

Value-Based Pricing

Vaccine Research

Economics of Innovation

Measuring and Valuing Outcomes

Policy, Organisation and Incentives in Health Systems

Value, Affordability and Decision Making
News

Events

Insights

Bulletin
Education Hub

OHE Graduate School

EVIA Programme
The Prize Fund

2024 Prize Fund

2022 Prize Fund

Events
About Us
OHE Experts
Join OHE
Contact Us

Newsletter SignupSubscribe

Filter results by

Theme

Select the product option you would like to filter Theme

Economics of Innovation Measuring and Valuing Outcomes Policy, Organisation and Incentives in Health Systems Value, Affordability, and Decision Making

Topic

Select the product option you would like to filter Topic

Antimicrobial Resistance (AMR) Biosimilars Cell and Gene Therapies Chronic Diseases Combination Therapies COVID-19 Research Dementia Digital Health Drug Development/R&D Emerging Markets EQ-5D and PROMs Health Care Systems Health Data and Statistics Health Technology Assessment (HTA) Indication-Based Pricing Innovation Policy Prize OHE Consulting Precision Medicine Prevention Real World Evidence (RWE) Research Sustainability Use of Medicines Vaccines Value-Based Pricing

Tag

Select the product option you would like to filter Tag

Adult Immunisation Alzheimer's Broader value and societal perspective in HTA Budget Impact Analysis Cancer Cardiovascular Disorders Care-givers Caring burden Cervical Cancer Clinical Outcomes Commentary Competition Dermatology Determining Value Diversity of Supply Drug Shortages Economic Evaluation Egypt Epidemiology and Public Health Epilepsy Gene therapies Generics Greece Haemophilia Health Policy and Regulation Health System Resiliency Healthcare Delivery Healthcare Expenditure Healthcare Funding Healthcare System Pressure (HCSP) India Infectious Diseases Inflation Reduction Act Injury and Trauma Innovation Israel Market Access Mental Health Pharmaceutical Industry Plant-based Policy Analysis Pricing and Reimbursement Primary Care Quality of Care Quality of Life Rare and Orphan Diseases Research Funding Resource Allocation Respiratory Cost Calculator Saudi Arabia Slovak Republic Societal preferences Supply of Medicine Türkiye Unmet Need Vaccines Value based pricing Webinar

Date 1

Select the product option you would like to filter Date

Date From

Month From

Year From

Date To

Month To

Year To

Author

Select the product option you would like to filter Author

Search authors

Neil Mcauslane Adam Raymakers Kiran Bhatti Kelsey Moore Meindert Boysen Pedro Pita Barros Andrew Briggs Thomas Pogge Antonella Cardone Stan Jackson

Content Type

Select the product option you would like to filter Content Type

news story insight events podcast bulletin publications

Health Care Systems
Value, Affordability, and…
Determining Value

The Value of Vaccines in Maintaining Health System Capacity in England

COVID-19 Research
Economics of Innovation
Determining Value

Working Towards a Sustainable, Healthy Market for Vaccines: a Comprehensive Framework to Support Policy Dialogue and Decision-Making

Economics of Innovation
Health Policy and Regulation

The Lower Drug Costs Now Act and Pharmaceutical Innovation

Combination Therapies
Value, Affordability, and…
Rare and Orphan Diseases

A Case Study Analysis: Challenges in the NICE Evaluation of Multi-Indication Medicines for Rare and Ultra-Rare Diseases

Insight
January 2021

Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Cancer Treatments

Health Technology Assessment…
Measuring and Valuing Outcomes

How is Quality of Life Measured for Health Technology Assessments?

Cell and Gene Therapies
Economics of Innovation
Market Access

Key Considerations for Early Access Schemes for Single-Administration (One-Time) Therapies

COVID-19 Research
Value, Affordability, and…
Health Policy and Regulation

Key Factors on How to Procure, Pay, Distribute and Use Vaccines for COVID-19: A European Perspective

Cell and Gene Therapies
Economics of Innovation
Health Policy and Regulation

Exploring the Financial Sustainability of Gene Therapies

Cell and Gene Therapies
Economics of Innovation
Health Policy and Regulation

The Promise of Gene Therapies: Are We Ready?

Health Technology Assessment…
Measuring and Valuing Outcomes
Cancer

Why we need a new Outcomes-based Value Attribution Framework for Combination Regimens in Oncology

COVID-19 Research
Value, Affordability, and…
Determining Value

Realising The Broader Value of Vaccines in the UK: Ready for Prime Time?

Health Care Systems
Policy, Organisation and…
Economic Evaluation

Resource Allocation in Public Sector Programmes: Does the Value of a Life Differ Between Governmental Departments?

News
December 2020

Should We ‘Drop Dead’ from Health State Valuation?

News
December 2020

How to Analyse EQ-5D Data? Methods for Analysing and Reporting EQ-5D Data: The Indispensable New Guide

Insight
December 2020

A NICE Wind of Change? The What and So What of the NICE Methods Consultation

Leading intellectual authority on global health economics

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Cookies Policy

An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Twitter

Facebook

Copy

Share on Mastodon

Enter your Mastodon instance URL (optional)

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Enable or Disable Cookies Enabled Disabled

Please enable Strictly Necessary Cookies first so that we can save your preferences!